About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Massachusetts | 508 Studies

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 508 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 508 trials

CompletedA Study of Enzalutamide and LY3023414 in Men With Prostate CancerThe main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.NCT02407054·Homewood, Alabama and 35 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingCopper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerThis is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate…NCT06235151·Homewood, Alabama and 42 others

CompletedA Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateThe purpose of this study is to collect follow-up safety data from participants in completed abiraterone acetate studies for a maximum duration of 9 years.NCT01517802·Aurora, Colorado and 21 others

CompletedET 743 (Yondelis) in Men With Advanced Prostate CancerThe main purpose of this study is to find out what effects (good or bad) trabectedin (ET743) has on men with advanced prostate carcinoma.NCT00147212·Boston, Massachusetts and 1 other

RecruitingA Study in Patients With Metastatic Castration-Resistant Prostate CancerThe goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resistant prostate cancer…NCT07719361·Los Angeles, California and 9 others

CompletedBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerThis phase II trial studies how well giving bicalutamide with or without Akt inhibitor MK2206 works in treating patients with previously treated prostate cancer.NCT01251861·Palo Alto, California and 197 others

SuspendedA Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesThe primary purpose of this study is to determine the maximally tolerated dose (MTD) of HGS1036 when used in combination with the standard chemotherapeutic regimens paclitaxel…NCT01604863·Scottsdale, Arizona and 1 other

SuspendedA Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NPX267 is an antibody drug targeting the inhibitory receptor for B7-H7 (HHLA2) which may control evasion of the immune response in tumors.NCT05958199·Baltimore, Maryland and 6 others

CompletedEffectiveness of Open and Robotic ProstatectomyProstate cancer is the most common cancer in American men. Surgical removal of the entire prostate (prostatectomy) is one option among the various ways to treat prostate cancer.NCT01325506·San Francisco, California and 8 others

RecruitingExercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE TrialThe purpose of this study is to determine whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with…NCT05918263·Boston, Massachusetts and 3 others

Active not recruitingA Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyThe purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with pelvic lymph node…NCT03767244·La Jolla, California and 202 others

CompletedTrial of ARV-110 and Abiraterone in Participants With Metastatic Prostate CancerPhase 1b study to assess the combination of ARV-110 (bavdegalutamide) and abiraterone in participants with metastatic prostate cancer with rising PSA values on abiraterone.NCT05177042·Santa Monica, California and 17 others

CompletedThe Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerThe purpose of this study is to evaluate the safety and optimal dose of RAD001 and docetaxel plus prednisone in men with hormone refractory, metastatic prostate cancer (Phase I).NCT00459186·Boston, Massachusetts and 4 others

RecruitingA Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics…NCT05652686·Duarte, California and 14 others

Active not recruitingA Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsThe purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.NCT06533059·La Jolla, California and 30 others

CompletedInterstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells.NCT00063882·Phoenix, Arizona and 169 others

CompletedA Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency…NCT02975934·Birmingham, Alabama and 149 others

WithdrawnAbemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerThis research is studying two experimental drugs, abemaciclib and atezolizumab, alone and in combination with each other, to learn about the safety and effectiveness of these…NCT04272645·Boston, Massachusetts and 3 others

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

PreviousPage 18 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma